Finance

Lists
FBRX:NASDAQ
Forte Biosciences Inc
USD 76,60
-0,49%
(-0,38) 1D
31 Jul., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBRX...
Open
USD 76,62
High
USD 76,74
Low
USD 76,54
Mkt. cap
1,57 mjd
Avg. vol.
1,73 m
Volume
78,00
52-wk high
USD 77,19
52-wk low
USD 9,22
EPS
-USD 4,58
Beta
2,85
Shares outstanding
20,48 m
No. of employees
22
Open
USD 76,62
High
USD 76,74
Low
USD 76,54
Mkt. cap
1,57 mjd
Avg. vol.
1,73 m
Volume
78,00
52-wk high
USD 77,19
52-wk low
USD 9,22
EPS
-USD 4,58
Beta
2,85
Shares outstanding
20,48 m
No. of employees
22
News stories
From sources across the web
About Forte Biosciences Inc
CEO-
Employees22
Founded2007
HeadquartersDallas, Texas, Verenigde State van Amerika
Sector-
Websitefortebiorx.com
Analyst ratings
Based on 6 analysts giving stock ratings to FBRX in the past 3 months
Buy
Buy
2
Hold
4
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for FBRX in the last 3 months.
Highest
Current USD 76,60
USD 77,00 (+0,52%)
Average
USD 74,00 (-3,39%)
Lowest
USD 61,00 (-20,37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Etzer Darout
Barclays
Hold
Downgraded
USD 77,00
+0,5%
07/27/2026
Kumaraguru Raja
Brookline Capital Markets
Hold
Downgraded
USD 77,00
+0,5%
07/27/2026
Gavin Clark-Gartner
Evercore ISI
Hold
Downgraded
USD 77,00
+0,5%
07/27/2026
Yaron Werber
TD Cowen
Hold
Downgraded
USD 77,00
+0,5%
07/27/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
USD 75,00
-2,1%
07/09/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
USD 61,00
-20,4%
05/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8,62 m
15,20 m
21,74 m
20,47 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,96 m
3,18 m
2,84 m
1,97 m
Operating expense
11,58 m
18,38 m
24,57 m
22,44 m
Total operating expenses
11,58 m
18,38 m
24,57 m
22,44 m
Operating income
-11,58 m
-18,38 m
-24,57 m
-22,44 m
Other non operating income
330,00 k
701,00 k
-1,65 m
676,00 k
EBT including unusual items
-11,25 m
-17,68 m
-23,75 m
-21,76 m
EBT excluding unusual items
-11,25 m
-17,68 m
-23,50 m
-21,76 m
Income tax expense
-
-
1,04 m
373,00 k
Effective tax rate
-
-
-4,37%
-1,71%
Other operating expenses
-
-
-
-
Net income
-11,25 m
-17,68 m
-24,79 m
-22,14 m
Net profit margin
-
-
-
-
Earnings per share
-0,96
-0,99
-1,45
-1,24
Interest and investment income
-
-
2,72 m
-
Interest expense
-
-
-
-
Net interest expenses
-
-
2,72 m
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-11,56 m
-18,37 m
-24,55 m
-22,42 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme